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Prevention of Staphylococcus aureus biofilm on dialysis cathe- A critical pathogenic step is the adherence of S. aureus
ters and adherence to human cells. to host cells or polymer surfaces and the subsequent
Background. Dialysis patients, often carriers of Staphylococ- accumulation of toxin-producing bacteria. A novel pro-
cus aureus in their nares, are at high risk of S. aureus infections.
phylactic approach is to prevent bacteria from adheringMethods. We examined whether RNAIII inhibiting peptide
and biofilm from forming, thus lessening the consequent(RIP), which interferes with quorum sensing mechanisms, re-
production of disease-causing toxins.duces adherence of S. aureus to host cells and to dialysis catheter
polymers in vitro. Adherence was tested by spectroscopy using The early stages of biofilm formation to devices such
safranin staining, by confocal scanning laser microscopy and as dialysis catheters involve adherence of bacteria to cell-
by atomic force microscopy. ular or matrix surfaces [4]. Further biofilm organization
Results. RIP inhibited bacterial adherence to HaCat and into complex structures is regulated by exchange of chem-HEp-2 cells and reduced adherence and biofilm formation not
ical signals between bacterial cells in a process knownonly on polystyrene, but also on both polyurethane- and sili-
as quorum sensing [5, 6]. The multicellular-like bacterialcone-made dialysis catheters, with a preponderant effect on
silicone, to which bacteria were more adherent. arrangement is associated with increased resistance to
Conclusion. RIP opens a new perspective in anti-S. aureus antibiotics [7]. A novel way to prevent colonization and
prophylaxis, particularly in dialysis patients. biofilm formation is to interfere with bacterial cell-cell
communication that leads to the virulence phenotype
[8]. RNAIII inhibiting peptide (RIP) inhibits such cell-
cell communication by interfering with quorum sensingStaphylococcal infections, particularly by Staphylococ-
mechanisms [6, 8–11]. Prevention of biofilm formationcus aureus, cause substantial morbidity and mortality in
by RIP may therefore not only decrease infection rate,hemo- and peritoneal dialysis patients. S. aureus carriage
but also preserve the residual bacteria’s susceptibility toin the anterior nares, a risk factor for infection, is about
antibiotics.twofold more prevalent in dialysis patients than in healthy
To date, two quorum sensing systems have been de-controls [1]. Seventy-five percent of dialysis patients with
scribed in S. aureus: one consists of the autoinducernasal carriage also carry S. aureus on their hands. Molec-
RNAIII-activating protein (RAP) and its target mole-ular typing has revealed that strains from nares, skin and
cule TRAP [6, 8]; the other consists of the peptide phero-infectious site are identical in 91% of cases [2]. Three-
mone AIP and its receptor AgrC [12, 13]. As the cellsweekly skin punctures of the vascular access site(s) and
multiply and the colony grows, the cells secrete RAP.the use of central venous hemodialysis and peritoneal dial-
When RAP reaches a threshold concentration, it inducesysis polymer-made catheters are other risk factors [3].
the histidine phosphorylation of its target molecule
TRAP [6]. The phosphorylation of TRAP leads, in a
yet unknown mechanism, to the activation of the gene
Key words: atomic force microscopy, dialysis access, quorum sensing,
regulatory system agr, which encodes for AIP and AgrCRIP, infection, hemodialysis, peritoneal dialysis, anterior nares, vascu-
lar access, bacteria. [12, 13]. AIP induces the phosphorylation of AgrC, lead-
ing to the production of the regulatory RNA molecule
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mal concentration of 10g/107 bacteria [10]. Unlike AIPs Atomic force microscopy
that require a thiolactone structure for activity [15] and About 1010 cells of early exponential S. aureus strain
use AgrC as their receptor, RIP is a linear peptide that 1 that was isolated from the nares of a dialysis patient
competes with RAP and inhibits the bacteria from pro- (discussed later in this article) were grown with or with-
ducing toxins [11] by inhibiting TRAP phosphorylation out RIP (10 g/107 bacteria) at 37C in culture plates
[6, 10]. RIP was already shown to protect animals from (60 mm polystyrene plates) for three hours. Plates were
keratitis, mastitis, arthritis, sepsis, cellulitis and osteomy- placed at 4C overnight. Unbound cells were removed
elitis, caused by various strains of staphylococci [8, 9]. by several washings with PBS, and cells that adhered to
the plastic were fixed with 2.5% glutaraldehyde for 15The present in vitro study examines whether RIP also
minutes at room temperature and rinsed with PBS. Bac-reduces S. aureus adherence both to human cells resem-
teria were imaged in PBS using atomic force microscopebling those of the anterior nares and skin, and to poly-
(BioScope; Digital Instruments, Santa Barbara, CA,mers of dialysis catheters.
USA) in tapping mode. V-shaped silicon nitride cantile-
vers with a nominal spring constant of 0.01 N/m (Park
METHODS Scientific Instruments, Sunnyvale, CA, USA) were used
for bacterial imaging. Typical resonance frequenciesBacteria
were chosen between 6 and 9 kHz. Images of bacteriaWild-type S. aureus strain RN6390B (ATCC 55620),
were obtained by a serial window narrowing, from theS. aureus RN6911, an agr-null strain [14], and nares-
typical 30 m scale in the first scan to a several hundredisolates of S. aureus obtained from 20 patients at the
nanometers scale in the final scan. Both the initial largeonset of maintenance hemodialysis. The most adherent
scan and following smaller scans were performed in the
strain, isolated from patient #7, is termed here as strain
scan rate range between 0.1 to 1.0 Hz to provide tip
1. The least adherent strain, isolated from patient #20, velocity of about 2 to 4 m/s.
is termed here as strain 20.
Adherence to dialysis catheters
Human cells
Staphylococcal aureus nasal strains from 20 dialysis
HaCat human skin keratinocytes and human epithelial patients were grown in broth to early exponential phase.
HEp-2 cells were grown at 37C in a 5% humidified in- Two hundred microliters of each strain (108 cells) were
cubator in bicarbonate-buffered Dulbecco’s modified applied in triplicates to 96-well culture polystyrene plates.
Eagle’s medium (DMEM) supplemented with 5% fetal The strains with highest (strain 1) or lowest (strain 20)
calf serum (FCS). adherence to polystyrene were further grown in wells
containing a 0.5 cm piece of sterile dialysis catheters
Adherence to human cells made of silicone (chronic silicone catheter; Horizon Medi-
cal Products, MA, USA) or polyurethane (single lumenS. aureus RN6390B cells were labeled with fluorescein
hemodialysis catheter; Gambro, Hechingen, Germany),isothiocyanate (FITC; Sigma Chemical Co., St. Louis,
with or without RIP (100 g/108 bacteria). Cells wereMO, USA) as described [10]. To test S. aureus adherence
grown without shaking (37C, 3 hours), non-adherentto human cells, 104 HaCat human skin keratinocytes or
cells removed, adherent cells stained (100L 0.1% safra-HEp-2 human epithelial cells were applied to Costar 96-
nin, 30 seconds), and unbound stain removed. Catheterswell cell culture polystyrene plates (Corning Inc., Corn-
containing stained bacteria were placed in a new well.ing, NY, USA) and grown to reach confluency at 37C in
Stained cells were dried (30 min, room temperature),a 5% CO2 humidified incubator in bicarbonate-buffered
100 L of 0.1% sodium dodecyl sulfate (SDS) in waterDMEM supplemented with 5% FCS. FITC-labeled bac-
was added for 30 minutes, the solution placed in a newteria [106 cells/well in 90 L phosphate-buffered saline
well and absorbance read at 490 nm.
(PBS)] were added to the confluent layer of host cells
without serum and with or without 5g RIP (synthesized Statistical analysis
in its amide form by Neosystem, Strasbourg, France). Statistical analysis was performed using the Student
Host and bacterial cells were incubated (30 min, 37C), t test. Values of P  0.05 were considered significant.
washed by PBS and fluorescence determined (485/530
nm) in a Microplate Fluorescence Reader (FL 600; Bio-
RESULTSTek, Winooski, VT, USA) using KC4 software. For con-
RIP reduces adherence of S. aureus to humanfocal scanning laser microscopy studies, bacterial and
keratinocytes and epithelial cellshuman cells were fixed (2.5% formalin), F actin was
labeled (Rh-phalloidin) [16] and cells were analyzed To test whether RIP can prevent S. aureus from colo-
nizing host cells, FITC-labeled wild-type S. aureus were(LSM 410; Zeiss, Oberkochen, Germany).
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Fig. 2. RIP reduces adherence of S. aureus to polystyrene. The atomic
force microscopy study used a larger scale to observe number of adher-
ent bacteria in a biofilm (A, B) and a smaller scale to observe adherence
of a single bacterium (C, D). S. aureus clinical strain 1 were applied to
polystyrene cell culture plates with RIP (B and D) or without RIP (A
and C) and cells observed using atomic force microscopy in tapping
mode. Amplitude images were collected and areas of cell attachment
were compared. The direction of scan is from left to right. The color
code of amplitude images corresponds to the changes in the amplitude
of tapping. Top bar (relevant for A and B) corresponds to 2.5 M.
Bottom bar (relevant for C and D) corresponds to 0.5 M.Fig. 1. RNAIII inhibiting peptide (RIP) reduces adherence of S. aureus
to HaCat cells. (A) FITC-labeled bacterial cells were applied to conflu-
ent HaCat cells with/without RIP. Adherent fluorescent bacteria were
measured at 485/530 nm. *P  0.05. (B) F actin was labeled with Rh-
phalloidin and cells analyzed by confocal scanning laser microscopy. ria to adhere to the plastic surface and then form aBacteria appear as light dots and actin filaments as light lines. Bar 
biofilm. The 20 S. aureus nares strains presented variable20 m.
degrees of adherence to polystyrene, with the most ad-
herent strain (strain 1) adhering fivefold more than least
adherence strain (strain 20). Therefore, strain 1 was usedincubated with/without RIP and with a confluent layer
to study adherence to plastic polymers in more detail byof keratinocytes (HaCat) or epithelial cells (HEp-2). Fig-
atomic force microscopy (AFM), which allows the exam-ure 1 shows the adherence of bacteria as determined by
ination of local adherence properties of a single bacte-measuring fluorescence level (Fig. 1A) and as observed
rium [10]. Figure 2 A and B show a general view of theby confocal scanning laser microscopy (Fig. 1B). RIP
biofilm formed on polystyrene by strain 1 with or withoutsignificantly (P  0.05) reduced the number of S. aureus
RIP, as studied by AFM. An almost confluent bacterialcells adhering to HaCat cells. Similar results were ob-
layer was seen in the absence of RIP (Fig. 2A), contrastingtained for HEp-2 cells (not shown).
with only very few remaining adherent cells in the pres-
RIP reduces catheter adherence and biofilm formation ence of RIP (Fig. 2B). In the presence of RIP, these few
of a strongly adherent S. aureus strain isolated from bacteria also attached less strongly, as observed by the
the nares of a dialysis patient amplitude images of a larger scale (Fig. 2 C, D). Ampli-
tude mode, which allows the steep parts of an object andTo test whether RIP can reduce biofilm formation of
particularly object borders to be emphasized, is illus-S. aureus on catheter polymers, strains isolated from the
trated in Figure 2C, a bacterial cell in the absence ofnares of 20 hemodialysis patients were used and their
RIP exhibiting a flat upper part (amplitude of tapping isadherence was first studied to polystyrene by growing
almost unperturbed) that gradually drops to the surface.bacteria for three hours in polystyrene wells and de-
The total contact area between bacterium and surfacetermining the number of adherent bacteria by safranin
staining. These experimental conditions allow the bacte- is much larger than the area of the upper flat part. In
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and RIP did not further reduce its adherence in the
concentration range tested. Adherence of strain 20 to
polyurethane was below detection level. These results
suggest that the effect of RIP is especially pronounced
in highly adherent strains.
To test if RIP affects S. aureus adhesion via agr, adher-
ence assays were carried out on S. aureus RN6911. This
strain is an agr-null strain and thus would be expected
to be highly adherent [14, 15]. As shown in Figure 3, RIP
significantly reduced adherence of S. aureus RN6911,
suggesting that RIP affects adherence by regulating gene
loci that are independent of agr.
DISCUSSION
Current strategies to prevent S. aureus infections in
dialysis patients consist of improved hygiene, the use of
anti-staphylococcal compounds either systemically (such
as rifampin) or topically (for example, mupirocin appli-
cation to the nares [17] or the catheter exit site), impreg-
nation of catheters with antimicrobial compounds, use
of an “antibiotic lock” to fill the catheter lumen during
the interdialytic interval [3] and, more recently, vaccina-
tion [18]. The present in vitro study examines a new
strategy: to impair adherence of S. aureus to critical host
Fig. 3. RIP reduces adherence of S. aureus to silicone (A) and to poly- cells and to dialysis catheters by using RIP.
urethane (B). Cells (S. aureus RN6911, strain 1 and strain 20) were We found that RIP decreases bacterial adherence toincubated with silicone- or polyurethane-made dialysis catheter frag-
human keratinocyte line HaCat. As anterior nares arements in the presence () or absence () of RIP. Adherent bacteria
were stained with safranin and absorbance was determined at 490 nm. lined by keratinocyte-like cells [1], our results suggest
that RIP may be used for reducing or eradicating nasal
carriage. Because the vast majority of S. aureus strains
isolated from infected sites are identical to those isolatedaddition, the bacterial cell has some protrusions scat-
in the anterior nares and on the skin [2], impairing bacte-tered over a large surface. In contrast, in the presence
rial adherence to anterior nares or skin cells by RIPof RIP (Fig. 2D), the bacterium has no visible protrusions
may be of critical importance to prevent the infectiousand transition from the upper part to the attached one
cascade. Studies are needed to compare the efficacy ofis very steep, making the cell appear much smaller. More-
the nasal application of either RIP or mupirocin, theover, the total area of bacterial adherence without RIP
latter being currently used for long-term eradication of(Fig. 2C) is at least four times larger than that of the
nasal carriage of S. aureus in hemo- and peritoneal dial-cell treated by RIP (Fig. 2D). These results indicate that
ysis patients [17].RIP decreases not only the number of attached bacteria,
RNAIII inhibiting peptide also decreases adherencebut also the contact area between the single bacterium
and biofilm formation of S. aureus strains isolated fromand the polystyrene surface, suggesting reduced adhe-
the nares of hemodialysis patients to several plastic mate-sion forces in the presence of RIP.
rials and in particular to dialysis catheters made of sili-Further studies were done on the adherence of strain 1
cone or polyurethane. The high degree of inhibition ofand strain 20 to more clinically relevant polymers, that
bacterial adherence to silicone by RIP is of interest, asis, silicone and polyurethane dialysis catheters. Bacteria
long-term catheters for hemo- and peritoneal dialysis arein the early exponential growth phase were added to
usually made of silicone. One potential application is topieces of these polymers, adherent bacteria were stained
coat dialysis catheters with RIP. Coating both the exter-with safranin and absorbance was determined. As shown
nal and the luminal surface of catheters may be morein Figure 3, adherence of strain 1 was approximately ten-
effective than coating only the luminal surface, as is thefold greater to silicone than to polyurethane (P  0.05).
case with the “antibiotic lock” technique, where a solu-Importantly, adherence of strain 1 both to silicone and
tion containing either heparin or citrate and an antimi-to polyurethane was significantly reduced in the presence
crobial compound is installed in the lumen of the hemo-of RIP (P  0.05). On the other hand, adherence of
strain 20 to silicone was relatively low to begin with, dialysis catheter at the end of dialysis [3]. The latter
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technique may be useful but is not designed to prevent The present results from an in vitro study obviously
S. aureus infections initiating at the catheter exit site. require confirmation in vivo. Using a rat model with sub-
Different technical approaches were used in this study cutaneous implantation of drug sensitive (MSSA) or drug
to assess adherence properties of S. aureus. Fluorescence resistant (MRSA) S. aureus-infected Dacron grafts, our
measurement and confocal scanning laser microscopy data indicate that RIP significantly reduces bacterial load
both indicated that significantly less bacteria adhered on the graft (Balaban et al, manuscript in preparation).
to host cells in the presence of RIP, spectroscopy with All together, our studies on adherence of S. aureus to
safranin staining showed that significantly less bacteria host cells and clinically relevant polymer materials
adhered to clinically relevant catheter polymers when clearly demonstrate that RIP reduces not only the num-
RIP was present, and finally the more sophisticated ber of adherent bacteria, but also bacterial adhesion
atomic force microscopy was used, showing at the single properties. These results support our hypothesis that RIP
bacterium level that RIP decreases the contact surface may be used to coat patient anterior nares and dialysis
and therefore adhesion forces between S. aureus and poly- catheters to prevent staphylococcal colonization and
styrene polymers. The fact that the results reached by consequent infections.
these different technical approaches converge strength-
ens our conclusion on the inhibitory effect of RIP on ACKNOWLEDGMENTS
adherence properties of S. aureus.
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